Top Chinese Pharma Companies Seeking Deals in the US

With additional reporting by Diane Alter – The top 20 Chinese pharmaceutical companies are seeking US acquisitions, taking advantage of a lull in healthcare M&A because of regulatory uncertainty to find bargains, said a sourcefeatured

No Apparent Remedy in Lattice Semiconductor/Canyon Bridge Deal

With additional reporting by Sarah Cohen – Lattice Semiconductor and Canyon Bridge jointly withdrew and refiled their voluntary notice to the Committee on Foreign Investment infeatured

Mofcom Approval of Syngenta/ChemChina Coming Soon

With additional reporting by Sarah Cohen – Mofcom approval of the Syngenta/ChemChina deal shouldfeatured

Monsanto/Bayer Deal Needs China’s Ministry of Agriculture Approval

The Monsanto/Bayer deal must be cleared by China’s Ministry of Agriculture as well as by Mofcom, a Chinese antitrust attorney familiar with the sector told CTFN. The attorney said that even though the dealfeatured

360b /

Congress Plans Broader Role for Security Reviews

In a rare bipartisan review, members of Congress are studying proposals that would expand the reach of the Committee on Foreign Investment in the United States that would likely add representation from additional federal agencies and allow CFIUS to probe deeper into M&A involving entities owned or partially owned by foreign governments.featured

MOFCOM Likely to Impose Conditions on Luxottica/Essilor Merger

Chinese antitrust regulator Mofcom is expected to impose some restrictions on the planned $50 billion merger between French optical lens maker Essilor and Italian eyewear leader Luxottica,featured

Interview: Former Monsanto Executive Talks Merger

Corrected & Updated:  CTFN’s Rachel Rigby interviewed Bernard Auxenfans, former Monsanto Worldwide Chief Operating Officer.  Auxenfans began his career with Monsanto in France, and held marketing and general management positions in the US, Canada, and Latin America before becoming worldwide COO of the Global Agriculture Sector. Auxenfans has the distinction of being the manager who … Read Morefeatured

360b /

Ingram Micro’s Federal Business May Not Require Sale

In the event that the Committee on Foreign Investment in the United States demands that Ingram Micro divest its federal business to proceed with its takeout by Tianjin Tianhai/HNA Group, the remedy might be as simple as terminating contracts, and need not require the sale of a business, suggested sources in the distribution, legal, and … Read Morefeatured

Investors Pay Heed to NDRC on Chinese Outbound M&A

With additional reporting by Rachel Rigby – Investors are generally aware of the roles Chinese regulators such as the State Administration of Foreign Exchange and the Ministry of Commerce of the Government of the People’s Republic of China play in reviewing transactions. However, SAFE and Mofcom are less influential than the National Development and Reform … Read Morefeatured

Zoomlion’s Shelved Bid Appears to Surprise Market

With additional reporting by Rachel Rigby – Zoomlion’s dropped bid for Terex appeared to surprise the market, as Terex shares traded down close to 20% Friday. “Although the parties to the transaction have made their joint efforts to closely negotiate on the proposed transaction recently, no agreement can be reached on the crucial terms,” Zoomlion said in a statement to the Hong Kong stock exchange earlier todayfeatured


Interested in a trial?

Simply fill out the form below and one of our representatives will be in touch.